CANCER
The results of a study published in ‘NEJM’ may represent an important paradigm shift in the standard treatment for this disease.
An immunotherapy that stimulates the immune system to destroy cancer has achieved an increase in the survival rate of patients with Hodgkin’s lymphoma up to a surprising 92% two years after starting treatment, which represents an important change in…
Session limit reached
- Access to Premium content is open courtesy of the establishment you are in, but right now there are too many users logged in at once. Please try again after a few minutes.
try again
You have exceeded the session limit
- You can only have three sessions started at a time. We have closed the oldest session so you can continue browsing the rest without limits.
Keep browsing
Article for subscribers only
Report a bug
#immune #therapy #achieves #survival #Hodgkin #lymphoma
